Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;17(3):207-9.
doi: 10.4103/0974-9233.65492.

Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma

Affiliations

Spontaneously Resolving Periocular Erythema and Ciliary Madarosis Following Intra-arterial Chemotherapy for Retinoblastoma

Brian Marr et al. Middle East Afr J Ophthalmol. 2010 Jul.

Abstract

Purpose and design: To describe an unusual clinical finding seen in children undergoing intra-arterial chemotherapy for retinoblastoma.

Materials and methods: A retrospective review of 69 eyes of 63 patients receiving intra-arterial chemotherapy over a 3-year period. Charts and photographs of 69 consecutive cases were reviewed, and data were collected on patients with clinical evidence of a hyperemic cutaneous periocular abnormality following the procedure.

Results: A blanching erythematous and edematous patch was noted in the periocular region in 16% (11 of 69) of the children who received intraarterial chemotherapy. The plaque extended into the region of the supertrochlear and medial marginal artery distribution on the ipsilateral side of the intra-arterial chemotherapy. All patches of erythema spontaneously resolved within 3 months following completion of the intra-arterial chemotherapy.

Conclusion: Periocular erythema and swelling is a self-limited clinical finding associated with intra-arterial chemotherapy in a small number of patients.

Keywords: Cancer; Eye; Intra-Arterial Chemotherapy; Melphalan; Retinoblastoma; Skin; Topotican.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

Figures

Figure 1
Figure 1
Ophthalmic artery angiogram of the left orbit, lateral, and posterior/anterior views
Figure 2
Figure 2
Hyperemic cutaneous periocular abnormality following intra-arterial chemotherapy for retinoblastoma. (a) Note the geographic erythematous plaque in the cutaneous area supplied by the supratrochlear and medial palpebral artery, also note the loss of the upper medial eyelashes. (b) See that the skin blanches with pressure. (c) Same patient 3 months following her last intra-arterial treatment. Note the resolution of the skin changes and eyelash loss

Similar articles

Cited by

References

    1. Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP. A phase I/II study of direct intra-arterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results. Ophthalmology. 2008;115:1398–404. - PubMed
    1. Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP. Bilateral superselective ophthalmic artery chemotherapy for bilateral retinoblastoma: Tandem therapy. Arch Ophthalmol. 2010;128:370–2. - PubMed
    1. Brodie SE, Pierre Gobin Y, Dunkel IJ, Kim JW, Abramson DH. Persistence of retinal function after selective ophthalmic artery chemotherapy infusion for retinoblastoma. Doc Ophthalmol. 2009;119:13–22. - PubMed
    1. Claudio F, Cacace F, Comella G, Coucourde F, Claudio L, Bevilacqua AM, et al. Intraarterial chemotherapy through carotid transposition in advanced head and neck cancer. Cancer. 1990;65:1465–71. - PubMed
    1. Landau M, Brenner S, Gat A, Klausner JM, Gutman M. Reticulate scleroderma after isolated limb perfusion with melphalan. J Am Acad Dermatol. 1998;39:1011–2. - PubMed